Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.

Item
http://www.wikidata.org/entity/Q36671291
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataThe cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncologyUsing activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityAn analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activationPro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma.Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.Chemo brain or tumor brain - that is the question: the presence of extracranial tumors profoundly affects molecular processes in the prefrontal cortex of TumorGraft mice.SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.Patient-derived xenografts as tools in pharmaceutical development.Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2.Common pathway signature in lung and liver fibrosis.Towards natural mimetics of metformin and rapamycin.A five-gene based risk score with high prognostic value in colorectal cancer.Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.
P2860

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.

Item
http://www.wikidata.org/entity/Q36671291
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pathway activation strength is ...... in colorectal cancer patients.
@ast
Pathway activation strength is ...... in colorectal cancer patients.
@en
type
label
Pathway activation strength is ...... in colorectal cancer patients.
@ast
Pathway activation strength is ...... in colorectal cancer patients.
@en
prefLabel
Pathway activation strength is ...... in colorectal cancer patients.
@ast
Pathway activation strength is ...... in colorectal cancer patients.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pathway activation strength is ...... in colorectal cancer patients.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P921
P932